BIOMAT Database Logo BIOMAT Database Logo

[Use of polyvinylpyridine N-oxide for treating experimental silicosis and anthracosilicosis]. 1977

V G Deĭnega, and L N Bolonova, and V V Sukhanov, and L F Zemliakova, and S V Tkachuk

UI MeSH Term Description Entries
D008297 Male Males
D011144 Polyvinylpyridine N-Oxide Inhibits the cytotoxic action of quartz and is reported to have delayed the development of experimental silicosis in rats. Bay 3504,Kexiping,Poly-2-vinylpyridine N-Oxide,Polyvinoxide,N-Oxide, Poly-2-vinylpyridine,N-Oxide, Polyvinylpyridine,Poly 2 vinylpyridine N Oxide,Polyvinylpyridine N Oxide
D011145 Polyvinyls POLYMERS derived from the monomer VINYL COMPOUNDS. Polyvinyl
D012138 Respiratory Therapy Care of patients with deficiencies and abnormalities associated with the cardiopulmonary system. It includes the therapeutic use of medical gases and their administrative apparatus, environmental control systems, humidification, aerosols, ventilatory support, bronchopulmonary drainage and exercise, respiratory rehabilitation, assistance with cardiopulmonary resuscitation, and maintenance of natural, artificial, and mechanical airways. Inhalation Therapy,Therapy, Inhalation,Therapy, Respiratory,Inhalation Therapies,Respiratory Therapies,Therapies, Inhalation,Therapies, Respiratory
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006821 Hyaluronoglucosaminidase An enzyme that catalyzes the random hydrolysis of 1,4-linkages between N-acetyl-beta-D-glucosamine and D-glucuronate residues in hyaluronate. (From Enzyme Nomenclature, 1992) There has been use as ANTINEOPLASTIC AGENTS to limit NEOPLASM METASTASIS. Hyaluronidase,Duran-Reynals Permeability Factor,GL Enzyme,Hyaglosidase,Hyaluronate Hydrolase,Wydase,Duran Reynals Permeability Factor,Factor, Duran-Reynals Permeability,Hydrolase, Hyaluronate,Permeability Factor, Duran-Reynals
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000874 Anthracosilicosis A form of pneumoconiosis caused by inhalation of dust that contains both CARBON and crystalline SILICON DIOXIDE. These foreign matters induce fibrous nodule formation in the lung. Anthracosilicoses
D012829 Silicosis A form of pneumoconiosis resulting from inhalation of dust containing crystalline form of SILICON DIOXIDE, usually in the form of quartz. Amorphous silica is relatively nontoxic. Silicoses

Related Publications

V G Deĭnega, and L N Bolonova, and V V Sukhanov, and L F Zemliakova, and S V Tkachuk
[Polyvinylpyridine-N-oxide and experimental silicosis].
June 1969, Gigiena truda i professional'nye zabolevaniia,
V G Deĭnega, and L N Bolonova, and V V Sukhanov, and L F Zemliakova, and S V Tkachuk
[Cytopharmacologic effect of using polyvinylpyridine-N-oxide in experimental silicosis].
March 1977, Biulleten' eksperimental'noi biologii i meditsiny,
V G Deĭnega, and L N Bolonova, and V V Sukhanov, and L F Zemliakova, and S V Tkachuk
The protective influence of polyvinylpyridine-N-oxide in experimental silicosis.
October 1963, La Medicina del lavoro,
V G Deĭnega, and L N Bolonova, and V V Sukhanov, and L F Zemliakova, and S V Tkachuk
[Inhibition of experimental silicosis by subcutaneous administration of polyvinylpyridine-N-oxide].
November 1961, Klinische Wochenschrift,
V G Deĭnega, and L N Bolonova, and V V Sukhanov, and L F Zemliakova, and S V Tkachuk
[Effect of polyvinylpyridine N-oxide on pulmonary tissue scleroproteins in experimental silicosis].
September 1978, Gigiena truda i professional'nye zabolevaniia,
V G Deĭnega, and L N Bolonova, and V V Sukhanov, and L F Zemliakova, and S V Tkachuk
[RECENT STUDIES ON THE INFLUENCE OF POLYVINYLPYRIDINE-N-OXIDE ON EXPERIMENTAL SILICOSIS].
January 1963, Grundfragen aus der Silikoseforschung,
V G Deĭnega, and L N Bolonova, and V V Sukhanov, and L F Zemliakova, and S V Tkachuk
[Effect of inhalations of polyvinylpyridine-N-oxide on the development of experimental silicosis].
January 1979, Farmakologiia i toksikologiia,
V G Deĭnega, and L N Bolonova, and V V Sukhanov, and L F Zemliakova, and S V Tkachuk
[Prophylactic action of polyvinylpyridine-N-oxide of different molecular weights on experimental silicosis].
April 1973, Gigiena i sanitariia,
V G Deĭnega, and L N Bolonova, and V V Sukhanov, and L F Zemliakova, and S V Tkachuk
[Action of polyvinylpyridine N-oxide on individual lung tissue indices in experimental silicosis].
October 1974, Gigiena truda i professional'nye zabolevaniia,
V G Deĭnega, and L N Bolonova, and V V Sukhanov, and L F Zemliakova, and S V Tkachuk
[Animal experimental fundamentals in the medicinal prevention of silicosis using polyvinylpyridine-N-oxide (P204)].
December 1968, Deutsche medizinische Wochenschrift (1946),
Copied contents to your clipboard!